within Pharmacolibrary.Drugs.V_Various.V10B_PainPalliationBoneSeekingAgents.V10BX01_Strontium89srChloride;

model Strontium89srChloride
  extends Pharmacolibrary.Drugs.ATC.V.V10BX01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V10BX01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Strontium (89Sr) chloride is a radiopharmaceutical used as a therapeutic agent primarily for the palliation of pain in patients with bone metastases from cancers such as prostate or breast cancer. It is typically administered as an intravenous injection. Strontium-89 mimics calcium and localizes to bone, especially areas of increased osteoblastic activity, delivering localized beta radiation to metastatic lesions. The drug is approved and used mainly in the context of metastatic bone pain palliation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic profile in adult cancer patients with bone metastases following intravenous administration.</p><h4>References</h4><ol><li><p>Argiro, G, et al., &amp; Sedda, AF (1998). A process for the recovery of strontium from the urine of patients injected with 89Sr. <i>Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine</i> 49(7) 777–778. DOI:<a href=\"https://doi.org/10.1016/s0969-8043(97)00301-1\">10.1016/s0969-8043(97)00301-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9570096/\">https://pubmed.ncbi.nlm.nih.gov/9570096</a></p></li><li><p>Henriksen, G, et al., &amp; Larsen, RH (2003). Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 44(2) 252–259. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12571218/\">https://pubmed.ncbi.nlm.nih.gov/12571218</a></p></li><li><p>Takahashi, S, et al., &amp; Kubota, Y (1989). The distribution and retention of 89Sr in mice after a single intravenous injection of high and low doses. <i>Journal of radiation research</i> 30(2) 176–184. DOI:<a href=\"https://doi.org/10.1269/jrr.30.176\">10.1269/jrr.30.176</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2738869/\">https://pubmed.ncbi.nlm.nih.gov/2738869</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Strontium89srChloride;
